Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
1.79%
Insider Ownership
5.50%
Institutional Own.
0.39%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
RTX-321 | HPV peptide antigen expression Details Solid tumor/s, Cancer, Human papillomavirus | Failed Discontinued | |
RTX-224 | 4-1BBL and IL-12 expression Details Solid tumor/s, Cancer | Failed Discontinued | |
RTX-240 | 4-1BBL & IL-15TP expression Details Solid tumor/s, Cancer, Non-small cell lung carcinoma, Renal cell carcinoma | Failed Discontinued |